drugset / Trial / NCT03703271
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
Phase 3
Recruiting
70 enrolled
Women's Hospital School Of Medicine Zhejiang University
Huazhong University of Science and Technology · collabQilu Hospital of Shandong University · collabSun Yat-sen University · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Study of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy
Timeline
- Start
- 2019-03-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 0.4 mg/kg | Intramuscular |